Phase II trial of epirubicin in gastric cancer.
Scarffe, J Howard Kenny, John B Johnson, Richard J Owens, Susan E Giles, G Leveson, S Maley, Wendy V
Scarffe, J Howard
Kenny, John B
Johnson, Richard J
Owens, Susan E
Giles, G
Leveson, S
Maley, Wendy V
Citations
Altmetric:
Abstract
Patients with advanced inoperable or recurrent adenocarcinoma of the stomach received an iv bolus of epirubicin (75 mg/m2) every 3 weeks. Partial responses were observed in four of 24 evaluable patients (17%). Treatment was generally well tolerated; a drop in left ventricular ejection fraction was observed in one patient who had received 450 mg/m2 of epirubicin.
Description
Date
1985-11
Publisher
Collections
Keywords
Anaemia
Stomach Cancer
Stomach Cancer
Type
Article
Citation
Phase II trial of epirubicin in gastric cancer. 1985, 69 (11):1275-7 Cancer Treat Rep